Kovack Advisors’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-24,408
Closed -$518K 611
2022
Q4
$518K Buy
+24,408
New +$506K 0.08% 275

Other funds holding BTAL

Kovack Advisors's BTAL Position: Q1 2023 in Review

Kovack Advisors sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q1 2023, closing a stake of 24,408 shares — an estimated $518K sold.

Kovack Advisors first reported a position in BTAL in Q4 2022 and held it in 1 quarter. The position peaked at $518K in Q4 2022. 89 funds tracked by Wall St. Rank hold BTAL as of Q1 2023.

  • Kovack Advisors reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q1 2023 after selling out during the quarter.
  • Kovack Advisors sold 24,408 AGF US Market Neutral Anti-Beta Fund shares in Q1 2023, an estimated $518K.
  • Kovack Advisors first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2022 and held it in 1 quarter.
  • Kovack Advisors's AGF US Market Neutral Anti-Beta Fund position peaked at $518K in Q4 2022.
  • 89 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q1 2023.

Based on Kovack Advisors's 13F filing for Q1 2023, filed 21 Apr 2023.